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ABSTRACT
The genome of influenza A viruses (IAV) is split
into eight viral RNAs (vRNAs) that are encapsidated
as viral ribonucleoproteins. The existence of a
segment-specific packaging mechanism is well es-
tablished, but the molecular basis of this mechan-
ism remains to be deciphered. Selective packaging
could be mediated by direct interaction between the
vRNA packaging regions, but such interactions have
never been demonstrated in virions. Recently, we
showed that the eight vRNAs of a human H3N2 IAV
form a single interaction network in vitro that
involves regions of the vRNAs known to contain
packaging signals in the case of H1N1 IAV strains.
Here, we show that the eight vRNAs of an avian
H5N2 IAV also form a single network of interactions
in vitro, but, interestingly, the interactions and the
regions of the vRNAs they involve differ from those
described for the human H3N2 virus. We identified
the vRNA sequences involved in five of these inter-
actions at the nucleotide level, and in two cases, we
validated the existence of the interaction using com-
pensatory mutations in the interacting sequences.
Electron tomography also revealed significant dif-
ferences in the interactions taking place between
viral ribonucleoproteins in H5N2 and H3N2 virions,
despite their canonical ‘7+1’ arrangement.
INTRODUCTION
Inﬂuenza A viruses (IAVs) are a serious threat to human
health (1). They are responsible for the majority of seasonal
ﬂu cases and for occasional ﬂu pandemics that can have
high case fatality and mortality rates (1). The IAV genome
consists of eight single-stranded viral RNA (vRNA)
segments of negative polarity ranging form 890 to
2341 nt, each encoding at least one essential protein in the
antisense orientation (2). In the viral particles, each vRNA
is associated with a trimeric viral polymerase complex and
numerous copies of the nucleoprotein (NP), forming a viral
ribonucleoprotein (vRNP) (2,3). The polymerase subunits,
basic protein (PB2), PB1 and acidic protein (PA), are
encoded by the three largest vRNAs, named vRNAs 1, 2
and 3, respectively. The polymerase complex recognizes the
50 and 30 termini of the vRNAs that are highly conserved
amongst IAV strains and among the eight vRNA species
(4–6). The 50 and 30 termini, which are 13 and 12 nt long,
respectively, are partially complementary and impose a
hairpin structure to the vRNPs (7,8).
While inﬂuenza B viruses almost exclusively infect
humans, the main reservoir of IAVs is constituted by
wild aquatic birds, such as ducks, geese and swans, and
the IAVs are much more diverse in the waterfowl than in
the human population (9). A human IAV pandemic can
arise when a ﬂu strain jumps from an animal species to the
human species and is transmitted efﬁciently in the human
population (1). An avian inﬂuenza virus can be trans-
mitted directly or indirectly to humans, without undergo-
ing major genetic changes: it is thought that such a process
gave rise to the ‘Spanish ﬂu’ in 1918. Alternatively, when
an animal and a human ﬂu strain co-infect an intermediate
host, such as a pig, the vRNAs from the two ﬂu strains can
mix to generate new strains (a process named genetic
reassortment) that can spread from the intermediate host
to humans. If the reassortant viruses contain ‘animal’
hemagglutinin (HA) and neuraminidase (NA) segments
that encode virus surface proteins for which humans
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have limited or no preexisting immunity, it can cause a
pandemic in the human population: this happened in 1957
(the ‘Asian ﬂu’), in 1968 (the ‘Hong Kong ﬂu’) and in 2009
(the ‘swine ﬂu’) (1,10).
The segmented nature of the IAV genome confers an
obvious evolutionary advantage, but it generates a for-
midable problem for the viral RNA packaging machinery
(3). Natural IAV infections are initiated at low multiplicity
of infection; therefore, viral particles that do not possess a
complete set of vRNAs will fail to replicate. IAVs rely on
a segment-speciﬁc packaging mechanism to ensure that
each viral particle contains one copy of each vRNA (3).
Indeed, IAVs normally incorporate one and only one copy
of each vRNA (11–14).
Defective interfering RNAs are generated in cell culture
and in vivo under high multiplicity of infection conditions
(15–24). They are generated during vRNA replication and
contain large deletions in the central coding region(s) (15–
17,19,20,22–24). Importantly, they speciﬁcally compete
for packaging into the viral particles with their parental
vRNA (18,19,21,23), indicating that vRNAs contain
segment-speciﬁc packaging signals. Sequencing of the de-
fective interfering RNAs indicated that these sequences
usually reside within 100–300 nt from each end of the
vRNAs. More recently, reverse genetics experiments,
mainly performed on the A/WSN/33 (H1N1) strain
(WSN), and to a lesser extent on the A/PR/8/34 (H1N1)
strain (PR8), revealed the existence of segment-speciﬁc
packaging signals in each vRNA, usually located within
100 nt from the vRNA ends (4,25–32). The packaging
sequences appear to be multipartite and discontinuous
(3). No precise boundary could be mapped in these experi-
ments: successive deletions from the middle to the border
of the coding regions resulted in a gradual decrease of the
packaging efﬁciency. Importantly, some, but not all,
conserved codons, which tend to accumulate in the
vRNA terminal regions, have been shown to be important
for optimal packaging of several vRNAs (33–35).
How the packaging signals ensure selective packaging of
a set of eight different vRNAs is still unknown, but the
existence of intermolecular interactions between vRNAs is
an attractive hypothesis, especially as no viral or human
protein speciﬁcally recognizing an IAV packaging signal
has been identiﬁed (3,26). However, no such interactions
have been identiﬁed in IAV viral particles. We therefore
recently developed an in vitro approach, which showed
that the eight vRNAs of the A/Moscow/10/99 (H3N2)
strain (MO) are involved in a single interaction network
(36). The vRNA regions involved in several interactions
were identiﬁed and were found to overlap with the regions
containing the WSN/PR8 packaging signals, even when
they could be narrowed down to a few nucleotides, sug-
gesting that the vRNA network detected in vitro is
relevant to IAV vRNA packaging (36). Combined with
electron tomography, which revealed the internal organ-
ization of MO virions, our in vitro data suggested that the
eight vRNAs are selected and packaged as an organized
supramolecular complex held together by direct base
pairing of the packaging signals (36).
Here, we applied the same strategy to an avian IAV:
the A/Finch/England/2051/91 (H5N2) strain (EN).
We showed that the eight vRNAs of the EN strain are
also involved in a single network of RNA interactions
in vitro. We grossly deﬁned the regions of the vRNAs
involved in each interaction, and in several cases, we
identiﬁed the interacting regions at the nucleotide level.
Surprisingly, neither the interaction network nor the
regions of the vRNAs involved in the intermolecular inter-
actions is conserved between the EN and MO strains.
Electron tomography also revealed signiﬁcant differences
in the organization of vRNPs in EN and MO virions.
Thus, our data suggest that the packaging signals might
not be conserved between these viral strains. The precise
identiﬁcation of the nucleotides involved in the vRNA/
vRNA interactions in vitro will allow testing their role in
IAV replication.
MATERIALS AND METHODS
Plasmids, cloning and site-directed mutagenesis
The EN complementary DNAs were cloned between the
BsmbI sites of pUC2000 vectors starting from the corres-
ponding reverse genetic plasmids. These vectors were
obtained as previously described and contain a T7
promoter, the cloning cassette of pHW2000 containing
two BsmbI sites, and a unique restriction site (Eco47III,
Bsh1236I or Ecl136II) between the PstI and EcoRI sites
(36). Sixty-seven mutants with deletions ranging from 11
to 400 nt have been obtained by polymerase chain
reaction using strictly complementary primers bridging
the region to be deleted. After 35 polymerase chain
reaction cycles, the parental plasmids were digested with
DpnI, and the ampliﬁcation products were used to trans-
form One Shot MAX efﬁciency DH5a-T1 (Invitrogen)
Escherichia coli cells. Fifteen mutants bearing point sub-
stitutions were obtained using the same strategy.
In vitro transcription, RNA puriﬁcation and
electrophoretic mobility shift assay
DNA templates digested with Eco47III, Bsh1236I or
Ecl136II were either co-transcribed in vitro by pairs, and
RNA complexes were analysed directly, or vRNAs were
synthesized individually, puriﬁed, and incubated with
another vRNA, followed by analysis of the complexes
by native agarose gel electrophoresis. Co-transcription ex-
periments were performed essentially as described previ-
ously (36). Brieﬂy, linearized plasmids (200 ng of each
plasmid) were incubated for 3 h at 37C and treated with
ribonuclease-free DNase I before analysis of the RNA
complexes. Alternatively, in vitro transcription of individ-
ual vRNAs was performed with 30 mg of linearized
plasmids essentially as described previously (37), except
that the concentration of each nucleotide triphosphate
(NTP) was 8mM, and that 0.5mg of yeast inorganic
pyrophosphatase (Roche) was included in the reaction
mixture. Following DNase I treatment, vRNAs were ex-
tracted with phenol/chloroform, ethanol precipitated and
puriﬁed on a TSK G2000SW column (Tosoh Bioscience)
as described previously (37). The integrity of the vRNAs
was routinely checked by denaturing polyacrylamide gel
electrophoresis. Pairs of puriﬁed vRNAs (2 pmol each)
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were denaturated for 2min at 90C in 8 ml of water and
cooled on ice. Two microlitres of 5-fold concentrated
buffer (ﬁnal concentration: 50mM sodium cacodylate,
pH 7.5; 40mMKCl and 0.1mMMgCl2) were added,
and the samples were incubated for 30min at 37C or
55C, then analysed on 0.8% agarose gels containing
0.01% (w/v) ethidium bromide after addition of 2 ml of
loading buffer [40% (v/v) glycerol, 0.05% (w/v)
xylene-cyanol and 0.05% (w/v) bromophenol blue].
Native gel electrophoresis of the RNA complexes was per-
formed at 4C in a buffer containing 50mMTris, 44.5mM
borate and 0.1mMMgCl2. The RNA weight fraction (%)
of each band in a lane was determined, and the percentage
of intermolecular complex was determined by dividing the
weight fraction of the corresponding band by the sum of
the weight fractions of all bands in the lane.
In oligo-mapping experiments, vRNAs were incubated
in the presence of 10 pmol of an oligodeoxyribonucleotide
(ODN) complementary to one of the vRNAs. A trace
amount (10 000–20 000 cpm) of 32P-50-labelled ODN was
included to be able to check its binding to the targeted
vRNA. To that aim, after imaging under ultraviolet light,
gels were ﬁxed for 10min in 10% (v/v) trichloroacetic
acid, dried at room temperature and submitted to
autoradiography.
Electron microscopy (EM) and tomography
Electron microscopy (EM) and electron tomography of
EN virus budding from Madin-Darby canine kidney
(MDCK) cells were performed as described previously
(36,38).
RESULTS
Optimization of the conditions for studying interactions
between EN vRNAs
We recently studied the interactions taking place between
the vRNAs of the IAV MO strain during in vitro tran-
scription (36). Mutational analysis of three of these inter-
actions showed that they involved the terminal regions of
the vRNAs open reading frames (36), which are known to
contain packaging signals [in the case of the human PR8
and WSN IAVs (3)], suggesting that the interactions
detected in vitro are relevant to vRNA packaging. When
we applied the same protocol to EN vRNAs, we observed
15 intermolecular interactions, but in only three of them
did the complex represent 20% of the RNA mass.
Besides, we observed that several EN vRNAs, but no
MO vRNAs, interacted with a green ﬂuorescent protein
(GFP) messenger RNA control under these conditions
(data not shown). Finally, we introduced a series of
200-nt deletions covering the complete vRNA 8 non-
structural (NS), but none of these deletions had a signiﬁ-
cant effect on its interaction with other EN vRNAs (data
not shown). Thus, we concluded that the experimental
conditions that allowed for speciﬁc interactions between
MO vRNAs are not well suited for EN vRNAs.
We thus individually transcribed EN vRNAs in larger
amounts and puriﬁed them, to be able to co-incubate them
by pairs under varying conditions. Based on the work on
retroviruses, which showed that different conditions have
to be used to analyse in vitro dimerization of the genomic
RNA of different viruses (39,40), we incubated all possible
pairs of EN vRNAs at varying ionic strengths and tem-
peratures. Only a few weak interactions were detected at
37C (data not shown), but these interactions and add-
itional ones were more clearly detected at 55C.
Surprisingly, they formed also more efﬁciently at low
ionic strength. We thus analysed the interactions
between EN vRNAs in a buffer containing 50mM
sodium cacodylate, pH 7.5; 40mMKCl and 0.1MgCl2.
EN vRNAs form a single interaction network
When incubated under these conditions, most individual
EN vRNAs migrated as a single band corresponding to
monomers (Figure 1 and Supplementary Figure S1). A
signiﬁcant band attributed to homodimeric species was
observed with vRNA 8 (coding for NS1 and NS2/
nuclear export protein (NEP)), and fainter dimeric
bands were observed with vRNAs 4 (coding for HA), 5
(coding for NP) and 7 (coding for M1 and M2).
Importantly, when pairs of EN vRNAs were
co-incubated, 13 additional bands corresponding to inter-
molecular complexes were detected (Figure 1A and
Supplementary Figure S1). Not all vRNA/vRNA inter-
actions were equally strong: four complexes accounted
for 7–17% of the RNA mass in the lane, ﬁve accounted
for 21–49% and four accounted for 65–82% (Figure 1B).
Each vRNA was involved in several interactions: three
vRNAs interacted with two partners, one interacted with
three partners, three interacted with four partners and one
(vRNA 2) interacted with ﬁve other vRNAs (Figure 1).
Remarkably, the network of interactions linking the EN
vRNAs is different from the one linking the MO vRNAs
(36). These two networks only share four interactions in
common: those between vRNAs 2 and 6 (coding for NA),
4 and 7, 4 and 8 and 5 and 8.
Identiﬁcation of the regions of the EN vRNAs involved
in intermolecular interactions in vitro
The regions of the vRNAs containing segment-speciﬁc
packaging signals have been mainly studied for WSN
and PR8, two human H1N1 strains of IAV (25,26,28–
35,41). These regions tend to be located towards the
ends of the vRNAs: most packaging signals are located
within 100 nt from both ends of the vRNA coding
regions. In the case of MO, we recently showed that
regions of the vRNAs involved in vRNA/vRNA inter-
actions in vitro correspond to regions identiﬁed as
packaging signals in WSN or/and PR8 (36). We therefore
introduced systematic deletions in all EN vRNAs, except
vRNA 6, to identify the regions involved in most vRNA/
vRNA interactions detected in vitro. Analysis of the
weakest interactions appeared technically more difﬁcult,
and we therefore did not attempt to identify the regions
of vRNA 6 interacting with vRNAs 1 and 2 (Figure 1B).
The vRNA 4/vRNA 7 interaction
We ﬁrst introduced deletions close to the ends of vRNA 7,
without affecting the promoter sequences, and tested their
Nucleic Acids Research, 2013, Vol. 41, No. 2 1243
effect on the interaction with vRNA 4. Surprisingly, none
of these deletions had a signiﬁcant impact on the inter-
action with vRNA 4 (Figure 2A, lanes 10 and 15). We thus
also constructed a series of deletion mutants covering the
central part of vRNA 7. Remarkably, one of them, ex-
tending from nucleotides 514–724 completely abolished
the interaction with vRNA 4 (Figure 2A, lane 13). In
addition, we observed that all but the 514–724 deletions
favoured homodimerization of vRNA 7 (Figure 2A, lanes
1 to 8). Similarly, we constructed a set of eight deletion
mutants covering the entire vRNA 4 sequence, except the
terminal promoters. Again, deletions close to the ends of
the vRNA had no effect on the interaction between
vRNAs 4 and 7 (Figure 2B, lanes 12 and 19). The most
pronounced effect on this interaction was observed for
the deletion covering nucleotides 613–857 of vRNA 4
(Figure 2B, lane 15). However, unlike deletion 514–724
in vRNA 7, deletion 613–857 did not totally abolish the
vRNA 4/vRNA 7 interaction. This might be an indication
that more than one region of vRNA 4 are involved in
this interaction (see later). Accordingly, several other de-
letions also weakened the interaction between vRNAs 4
and 7, albeit less dramatically (Figure 2B, lanes 13–14 and
16–18).
The vRNA 1/vRNA 2 interaction
We next introduced sequential deletions in vRNAs 1 and 2
to delineate the regions involved in the intermolecular
interaction between these two vRNAs. None of the
vRNA 1 and vRNA 2 deletion mutants formed
Figure 1. The eight EN vRNAs form a single interaction network in vitro. (A) Analysis of vRNA/vRNA interactions by agarose gel gelectrophoresis.
Individual vRNAs are indicated by arrows and intermolecular complexes are marked by asterisks. (B) Quantiﬁcation of the complexes. The weight
fraction (%) of the RNA migrating as an intermolecular complex is expressed as mean±standard error of the mean (n=3–9).
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homodimers, and they all migrated as expected based on
their size (Figure 3 and data not shown). One deletion in
vRNA 2, encompassing nucleotides 1939–2198 had a
dramatic effect on the vRNA 1/vRNA 2 interaction
(Figure 3A, lane 12). Deletion of nucleotides 785–1170
in vRNA 1 had a similar effect (Figure 3B, lane 6).
These two deletions had major effects but did not com-
pletely abolish the interaction, suggesting minor contribu-
tions from other regions of both vRNAs.
The vRNA 3/vRNA 8 interaction
We next studied the interaction between vRNAs 3 and 8
(Figure 4). As already mentioned, vRNA 8 signiﬁcantly
dimerized, and dimerization was also observed with all
vRNA 8 mutants, except those in which nucleotides 235–
456 or 435–656 were deleted (Figure 4A, lanes 1–7). Several
deletions in this RNA had an impact on the interaction
with vRNA 3: deletion of nucleotides 435–656 totally abol-
ished the intermolecular interaction, whereas deletion of
nucleotides 235–456 had a drastic effect, although some
complex was still detected (Figure 4A, lanes 13 and 14).
One possibility is that region 435–456 of vRNA 8, which
was deleted in both mutants, is involved in the interaction
with vRNA 3, together with downstream sequences. In
addition, deletion of nucleotides 635–834 also had a notice-
able, althoughmore limited, effect on the vRNA 3/vRNA 8
interaction (Figure 4A, lane 15). Similarly, the analysis of
vRNA 3 showed that deletion of nucleotides 125–514
totally abolished the intermolecular interaction (Figure
4B, lane 5), whereas deletions in the 515–2230 region had
a limited but signiﬁcant negative impact on this interaction
(Figure 4B, lanes 6–10).
General features of the EN vRNA/vRNA interactions
The strategy detailed previously for interactions between
vRNAs 4 and 7, 1 and 2 and 3 and 8 was applied to all
interactions detected in vitro, and allowed to gain infor-
mation on the regions of the vRNAs involved in most of
Figure 3. Region 1939–2198 of vRNA 2 and region 785–1170 of vRNA 1 are required for optimal interaction between these vRNAs. Deletions were
introduced in vRNA 2 (A) or vRNA 1 (B), and formation of the intermolecular complex was monitored by agarose gel electrophoresis.
Figure 2. Region 514–724 of vRNA 7 and region 613–857 of vRNA 4 are required for optimal interaction between these vRNAs. Deletions were
introduced in vRNA 7 (A) or vRNA 4 (B), and formation of the intermolecular complex was monitored by agarose gel electrophoresis.
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them (Figure 5, Supplementary Figures S2 and S3 and
data not shown). In many cases, several (usually contigu-
ous) deletions affect a given interaction, but one deletion
has usually a more pronounced effect than the other ones,
suggesting that it constitutes the main interacting domain,
and only this region has been reported in Figure 5. The
deletions that have less pronounced effects may either cor-
respond to secondary interaction sites or affect the
Figure 5. Summary of the vRNA regions involved in intermolecular vRNA interactions. vRNAs have different colours and are drawn to scale.
Regions deﬁned by deletion analysis are presented by rectangles that have the same colour as the interacting vRNA. Note that when only one of
several overlapping deletions affects the interaction between two vRNAs, the region required for the interaction is shorter than this deletion, as the
overlapping sequences are not required. Deletions that have limited effects are indicated by question marks. Sequences identiﬁed by ODN mapping
or/and site-directed mutagenesis are indicated by asterisks.
Figure 4. Optimal interaction between vRNAs 3 and 8 requires region 435–656 of vRNA 8 and region 125–514 of vRNA 3. Deletions were
introduced in vRNA 8 (A) or vRNA 3 (B), and formation of the intermolecular complex was monitored by agarose gel electrophoresis.
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interaction indirectly by affecting the vRNA structure.
However, in the case of the vRNA 3/vRNA 5 interaction,
two non-overlapping adjacent deletions in vRNA 5 com-
pletely abolished the interaction with vRNA 3 (Figure 5),
suggesting that the sequence of vRNA 5 interacting with
vRNA 3 is located close to the junction between these two
deletions (i.e. nt 1419). In contrast with our recent report
on MO vRNAs (36) and with the location of the PR8 and
WSN packaging regions (3), the regions involved EN
vRNA/vRNA interactions are usually located >100 nt
from the ends of the coding regions. The only exception
could be the region of vRNA 5 interacting with vRNA 3,
which remains to be delineated more precisely (see earlier
in text and Figure 5). Deletion of nucleotides 635–834 of
vRNA 8 abolished interaction with vRNA 5 (Figure 5 and
Supplementary Figure S3), but deletion of nucleotides
765–877 did not (Supplementary Figure S3, lane 5),
indicating that the region of vRNA 8 interacting with
vRNA 5 is located >100 nt away from the 50 end of the
coding region of this vRNA. Remarkably, several regions
of interaction are located close to the middle of the
vRNAs (Figure 5). Deletion analysis of vRNA 1 did not
allow to identify a region of this vRNA required for the
interaction with vRNA 6 because none of the deletion
signiﬁcantly impaired this interaction. Deleting nucleo-
tides 125–384 in vRNA 2 decreased the interaction with
vRNA 6, but the effect was modest. As these two inter-
actions appeared difﬁcult to analyse, we did no attempt to
identify the regions of vRNA 6 they involve.
Precise identiﬁcation of the sequences of EN vRNAs
involved in vRNA/vRNA interactions
We next attempted to precisely identify the nucleotides
involved in several vRNA/vRNA interactions. When
deletion experiments allowed us to identify the region of
one vRNA involved in an intermolecular interaction, we
used a series of antisense ODNs spanning this region to
reﬁne the interaction zone. Sequence analysis then usually
allowed to propose a limited number of possible inter-
actions between the zone identiﬁed by ODN scanning on
one vRNA and the region identiﬁed by deletion on the
other vRNA. These possible interactions were then
tested with ODNs complementary to the second vRNA.
When many interactions were possible, a systematic ODN
scan of the longer vRNA was performed.
The vRNA 4/vRNA 8 interaction
A ﬁrst example of this strategy is shown in Figure 6 for the
interaction between vRNA 4 and 8. Deletion analysis
indicated that region 257–434 of vRNA 8 interacts with
vRNA 4 (Supplementary Figure S2B, lanes 6–8). Two
adjacent ODNs complementary to nucleotides 346–375
and 376–405 almost totally abolished the vRNA
4/vRNA 8 interaction (Figure 6A, lanes 7–8). Knowing,
that in vRNA 4, the region of interaction is located
between nucleotides 368 and 612 (Supplementary Figure
S2A), the likeliest interaction is between nucleotides 364–
374 of vRNA8 and nucleotides 449–459 of vRNA 4
(Figure 6B): it involves six G-C and four A-U base-pairs,
as well as a non-canonical G-A base pair. The existence of
this interaction is inferred from the inhibitory effect of
ODNs complementary to nucleotides 442–466 of vRNA
4 and to nucleotides 357–381 of vRNA 8 (Figure 6C).
Note that the ODN complementary to nucleotides 346–
375 of vRNA 8 also directly targets this interaction,
whereas the ODN complementary to nucleotides 376–
405 hybridizes immediately adjacent to that region and
probably has an indirect effect (Figure 6A and C).
The vRNA 5/vRNA 8 interaction
Among a series of nine ODNs targeting region 1165–1419
of vRNA 5 identiﬁed by deletion analysis (Supplementary
Figure S3B), two adjacent ODNs complementary to nu-
cleotides 1193–1222 and 1223–1252, respectively, dramat-
ically inhibited the interaction between vRNAs 5 and 8
(Figure 7A, lanes 5 and 6). Interestingly, nucleotides
1216–1226 of vRNA 5 are strictly complementary to nu-
cleotides 660–670 of vRNA 8 (Figure 7B), which are
located in region 657–764 identiﬁed by deletion analysis
of this vRNA (Supplementary Figure S3A). As predicted,
an anti-vRNA 8 ODN targeting nucleotides 654–676 also
abolished the interaction between vRNAs 5 and 8, support-
ing the existence of the proposed base pairing between these
vRNAs (Figure 7C).
The vRNA 4/vRNA 7 interaction
Region 514–724 of vRNA 7 is involved in the interaction
with vRNA 4 (Figure 2A), and ODN mapping of this
region revealed that an anti-vRNA 7ODN complementary
to nucleotides 605–634 strongly inhibited this interaction
(Figure 8A). Sequence analysis revealed that nucleotides
595–608 of vRNA 7 can form 14 consecutive base pairs,
including 3G-U base pairs, with nucleotides 654–667 of
vRNA 4 (Figure 8B, interaction 1). However, none of the
ODNs complementary to region 613–857 identiﬁed by
deletion analysis (Figure 2B) had any signiﬁcant effect on
the interaction between vRNAs 4 and 7 (Figure 8C).
Further sequence analysis revealed that nucleotides 626–
633 of vRNA 7 are complementary to nucleotides 336–
343 of vRNA 4 (Figure 8B, interaction 2). This interaction
would also explain the inhibitory effect of the anti-vRNA 7
605–634 ODN (Figure 8A). However, an anti-vRNA 4
ODN targeting nucleotides 325–354 did not affect the inter-
action between vRNAs 4 and 7 (Figure 8D, lane 7). We
thus suspected that interactions 1 and 2 might coexist,
and this indeed appeared to be the case: the interaction
between vRNAs 4 and 7 was drastically inhibited when
two anti-vRNA 4 ODNs targeting, respectively, nucleo-
tides 325–354 and 646–675 were co-incubated with the
vRNAs (Figure 8E, lane 11). When substituting mutant
vRNAs 4 with a deletion preventing one of the interactions
for the WT vRNA 4, the anti-vRNA 4 ODN targeting the
other interaction was sufﬁcient to prevent formation of the
vRNA 4/vRNA 7 complex (Figure 8E, lanes 6, 9 and 10).
This represents the only case in which we identiﬁed two
base pairings that are each sufﬁcient to maintain the inter-
action between vRNAs at almost WT level.
The vRNA 3/vRNA 8 interaction
Deletion analysis of vRNA 8 revealed that region 235–
456, and especially nucleotides 435–656, are involved in
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the interaction with vRNA 3 (Figure 4A). None of the
ODNs targeting the ﬁrst of these regions had a potent
inhibitory effect (Figure 9A), but two ODNs targeting
nucleotides 495–524 and 525–554, respectively, abolished
the interaction between vRNAs 3 and 8. Sequence analysis
revealed two possible interactions between this region of
vRNA 8 and region 125–514 of vRNA 3 (Figure 9C),
which was identiﬁed by deletion mutations (Figure 4B).
Anti-vRNA 3 ODNs selectively targeting interaction 1
or 2 supported the existence of interaction 1 only
(Figure 9D). To further validate this result, we introduced
compensatory mutations in the sequences of vRNAs 3 and
8 involved in interaction 1 (Figure 9E). As expected,
introducing mutations in only one of the vRNAs abol-
ished the interaction (Figure 9F, lanes 6 and 7), whereas
combining the two mutated vRNA restored it (Figure 9F,
lane 8), albeit not at the WT level.
The vRNA 1/vRNA 2 interaction
Mapping of region 1939–2198 of vRNA 2, previously
identiﬁed by deletion mutagenesis (Figure 3A), using
anti-vRNA 2 ODNs identiﬁed region 2059–2118
as playing a role in the interaction with vRNA 1
(Figure 10A). The reciprocal experiment performed on
region 781–1170 of vRNA 1 allowed us to delineate a
region interacting with vRNA 2 within nucleotides 961–
1020 (Figure 10B), but region 841–870 also seemed to play
some role in the interaction between vRNAs 1 and 2.
Bioinformatic analysis of the vRNA 1 and vRNA 2 se-
quences identiﬁed two interactions that could explain the
effect of these regions (Figure 10C). However, the
sequence of vRNA 2 involved in interaction 2 falls outside
the region identiﬁed by ODN mapping (Figure 10A). To
further establish the role of interaction 1 in the interaction
between vRNAs 1 and 2, we introduced complementary
Figure 7. Interaction between vRNAs 5 and 8 involves nucleotides 1193–1252 of vRNA 5 and nucleotides 654–676 of vRNA 8. (A) ODNs were used
to map region 1163–1432 of vRNA 5. (B) Proposed interaction between vRNAs 5 and 8. (C) ODNs complementary to vRNAs 5 and 8 were used to
test the proposed interaction.
Figure 6. Nucleotides 357–381 of vRNA 8 and nucleotides 442–466 of vRNA 4 are involved in the interaction between these vRNAs. (A) ODNs
were used to map region 257–464 of vRNA 8. (B) Proposed interaction between vRNAs 4 and 8. (C) ODNs complementary to vRNAs 4 and 8 were
used to test the proposed interaction.
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mutations in these vRNAs (Figure 10D). When using only
one mutated vRNA, the interaction was strongly reduced,
but combining the two mutated vRNAs restored this
interaction to WT levels (Figure 10E).
EM and tomography
Our in vitro data showed that the network of interactions
linking the EN vRNAs differs from the recently deﬁned
MO interaction network (36): different interactions that
tend to involve different regions of the vRNAs were
observed. If these (or at least some of these) interactions
exist in virions, one would expect differences in the
internal organization of EN and MO viruses. Using EM,
zero to eight dots corresponding to vRNPs can be
observed in transversal sections of EN viruses budding
from MDCK cells (Figure 11A). When eight vRNPs are
visible, seven vRNPs surround a central one (Figure 11A).
These EM pictures indicate that the overall disposition of
the vRNPs is similar in EN virions (Figure 11A) and in
MO (36), WSN (42,43) and PR8 (42) virions.
In electron tomography, cross-sections of individual EN
virions revealed three different zones (Figure 11B and
Supplementary Figure S4). In the central part of the
virions, vRNPs appeared as individual round dots, but
contacts were frequently observed between the dots
(panels 5–10 of Figure 11B and panels 6–10 of
Supplementary Figure S4). The apical part of the
budding virions constitutes a transition zone, in which
the dots corresponding to vRNPs progressively become
elongated and smaller; density appears between the
vRNPs and ﬁnally, just below the matrix layer, the indi-
vidual vRNPs are not visible anymore (Figure 11B, panels
11–15 and Supplementary Figure S4, panels 11–15).
Unexpectedly, the vRNPs also appeared as smaller
elongated dots in the region of the virion that is closer
from the producer cell. Numerous contacts were
observed in this region (Supplementary Figure S4,
panels 2–5), and it was frequently impossible to visualize
the individual vRNPs (Figure 11B, panels 2–5).
DISCUSSION
Increasing evidence [reviewed in (3)] support the idea that
the eight vRNPs constituting the IAV genome are select-
ively packaged into virions. Since the ﬁrst demonstration
of the existence of segment-speciﬁc packaging regions in
Figure 8. Alternative interactions between vRNAs 4 and 7. (A) ODNs were used to map region 514–724 of vRNA 7. (B) Proposed interactions
between vRNAs 4 and 7. (C) ODNs were used to map region 613–867 of vRNA 4. (D) Anti-vRNA 4 and anti-vRNA 7 ODNs were used to test the
two proposed interactions. (E) Combinations of anti-vRNA 4 ODNs or of an anti-vRNA 4 ODN and a vRNA 4 deletion mutant were used to test
the coexistence of the two proposed interactions.
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an IAV vRNA using reverse genetics, direct interactions
between vRNAs appeared as an attractive hypothesis to
explain this process (26). This hypothesis is reinforced by
the fact that no viral or cellular protein speciﬁcally
recognizing an IAV segment-speciﬁc packaging signal
has been identiﬁed so far. However, demonstrating the
existence of speciﬁc vRNA/vRNA interactions in viral
particles without any knowledge of the sequences that
might be involved is challenging, and no such interaction
has been identiﬁed, in vivo, to date.
We recently analysed the interactions taking place
between the MO vRNAs in vitro (36). We found that the
eight MO vRNAs are involved in a single network of
interactions, and we showed that the regions of the
vRNAs that are involved in three of the main interactions
in vitro correspond, in the case of PR8 or WSN IAV, to
regions containing packaging signals (36). We also
detected many contacts between vRNPs, likely involving
the packaging regions, using electron tomography, sug-
gesting that the eight vRNPs are co-packaged as a supra-
molecular complex (36). Because little is known about the
selective packaging of avian IAVs, we applied the same
strategy to EN, an avian H5N2 IAV. As for MO, we
found that the eight vRNAs are involved in a single inter-
action network (Figure 1).
However, marked differences between the MO and EN
viruses were observed in our biochemical experiments.
First, the experimental conditions allowing detection of
speciﬁc interactions between vRNAs are different. The
retrovirology ﬁeld taught us that it is necessary to use
different conditions, including temperature, to study di-
merization of different viral RNAs: for instance, the
optimal temperature for studying in vitro RNA dimeriza-
tion is 37C for human immunodeﬁciency virus-1 (39),
50C for avian leukosis virus (44) and 55C for murine
leukemia virus (40). In our previous study on the human
MO IAV, we detected speciﬁc interactions during in vitro
transcription, which was performed at 37C. In the case of
the avian EN IAV, 55C allowed speciﬁc detection of
vRNA/vRNA interactions, whereas 37C did not, but
we have not systematically tested all intermediate tem-
peratures. Incidentally, it has to be kept in mind that
human IAVs replicate in the upper respiratory tract,
where the temperature is 33C, whereas avian IAVs repli-
cate at 40C, in the intestine of birds. Second, most inter-
actions were observed in only one of the two viruses, and
third, the regions of the vRNAs involved in these inter-
actions are globally different. In MO, the vRNA/vRNA
interactions were usually affected by deletions at the ends
of the coding sequences (36), whereas here we observed
Figure 9. Nucleotides 389–402 in vRNA 3 interact with nucleotides 514–527 in vRNA 8. ODNs were used to map region 257–464 (A) and 465–554
(B) of vRNA 8. (C) Proposed interactions between vRNAs 3 and 8. (D) ODNs complementary to vRNAs 3 and 8 were used to test the two proposed
interactions. (E) Compensatory mutations introduced in vRNAs 3 and 8 to test interaction 1. (F) Effects of mutations in vRNAs 3 or/and 8 on the
intermolecular interaction.
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that interactions between vRNAs are mediated by more
central sequences (Figures 2–10 and Supplementary
Figure S2 and S3). Even though the interaction
networks are remarkably different between MO and EN
viruses, it should be noted that some central regions might
also play a role in the interaction between MO vRNAs
(e.g. the central region of vRNA 4 in the vRNA 4/vRNA 7
interaction) (36).
We detected 13 intermolecular interactions between EN
vRNAs (Figure 1), compared with only eight between MO
vRNAs (36), and it is unclear whether all these inter-
actions could take place within a single virion. It is
possible that within virions, only a subset of these inter-
actions, which could differ from one virion to another, do
take place: this would explain the observation that the
relative disposition of the eight vRNPs is not strictly
conserved among MO or WSN virions (36,43). Besides,
some of the interactions between EN vRNAs were fairly
weak (e.g. between vRNAs 1 and 6, 2 and 6 and 4 and 8;
Figure 1), and may not exist in virions, although they were
reproducibly observed in vitro. However, vRNAs are
packaged as vRNPs, and crystal structures of the NP
protein suggested that vRNAs bind at the surface of the
protein oligomers (45,46). In addition, chemical probing
indicated that NP increases the accessibility of the vRNA
bases (47). Thus, NP might facilitate intermolecular inter-
actions between vRNAs, rather than prevent them.
EM and tomography revealed that the eight vRNPs are
attached at the matrix layer at the tip of budding virions
(36,42,43,48,49). Therefore, the interactions involving se-
quences located at similar distances from either ends of the
two vRNAs are more likely to take place in virions: this is
for instance the case of the interactions between vRNAs 2
and 3, 2 and 4, 2 and 8, 3 and 8, 4 and 7 and 4 and 8
(Figure 5). In the case of vRNAs 4 and 7, we detected two
alternative interactions in vitro (Figure 8), but based on
the argument developed previously, interaction 2 depicted
in Figure 8B is more likely to take place in virions than
interaction 1.
Electron tomography of budding EN virions (Figure 11
and Supplementary Figure S4) also revealed signiﬁcant
differences with MO (36) and WSN (43) virions.
Figure 10. Nucleotides 982–994 in vRNA 1 interact with nucleotides 2075–2087 in vRNA 2. ODNs were used to map region 1939–2208 of vRNA 2
(A) and region 781–1170 of vRNA 1 (B). (C) Proposed interactions between vRNAs 1 and 2. (D) Compensatory mutations introduced in vRNAs 1
and 2 to test interaction 1. (E) Effects of mutations in vRNAs 1 or/and 2 on the intermolecular interaction.
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Towards the budding tip of the EN virions, the vRNPs
appeared as small elongated dots; numerous contacts were
observed between these dots, to a point that it progres-
sively became impossible to distinguish the individual
vRNPs (Figure11 and Supplementary Figure S4). This ob-
servation is reminiscent of the tomograms obtained with
MO and WSN virions (36,43). In the middle of the viral
particles, EN vRNPs appeared as larger round dots.
Numerous contacts were also observed between vRNPs
in this region of the tomograms, and the vRNPs some-
times appeared connected by a thin linker (Figure 11 and
Supplementary Figure S4). Such contacts were also fre-
quently observed in WSN virions (43), but were rare in
MO virions (36). In the lower part of most tomograms of
EN virions, vRNPs again appeared elongated and in close
contact, and it was frequently impossible to distinguish the
individual vRNPs (Figure 11 and Supplementary Figure
S4). In this region, EN virions differ from MO and WSN
virions, in which individual vRNPs can be observed
(36,43). Considering that vRNPs adopt a panhandle struc-
ture in virions (7,8,50), the numerous contacts that we
have observed in the central and lower part of EN
virions (Figure 11 and Supplementary Figure S4), but
not MO virions (36), are consistent with interactions
involving sequences distributed all along the EN
vRNAs, as we observed in vitro (Figure 5).
Figure 11. Electron microscopy (A) and electron tomography (B) of EN viral particles budding from MDCK cells. (A) Cross-sections of budding
EN virions. A viral particle in which the eight individual vRNPs form a typical ‘7+1’ arrangement is circled. (B) Successive virtual cross-sections of
an EN virion, from the bottom to the budding tip of the viral particle.
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Our in vitro studies suggest that different vRNA/vRNA
interactions might underlie the selective packaging of
vRNAs in different IAVs. In the present study, we
identiﬁed ﬁve intermolecular interactions between EN
vRNAs at the nucleotide level, and sequence compari-
son shows that they are not conserved in the MO and
PR8 IAV strains (Supplementary Figure S5). This idea
might seem contradictory with the observation that
conserved codons tend to accumulate in the regions of
the vRNAs known to contain packaging and with the
fact that mutations of some of these codons affect
vRNA packaging (33–35). However, some of these
conserved codons appeared to be important for vRNA
packaging in WSN, but not PR8 (35), indicating that
some packaging signals are not conserved, even among
human IAVs of the same serotype. The fact that the se-
quences involved in the interactions between the EN
vRNAs are not conserved in the MO and PR8 IAV
strains is consistent with the observation that EN and
MO vRNAs establish different networks of intermolecular
interactions in vitro. This lack of conservation could have
major consequences for genetic reassortment by creating
genomic incompatibilities between vRNAs from different
IAVs. Indeed, by studying genetic reassortment between
EN and MO viruses, we recently demonstrated that
reassortment between these two viruses is restricted at
the level of the vRNAs themselves, and not only at the
protein level (Essere, B. Yver, M. et al., submitted for
publication).
The ultimate step of our strategy will be to demonstrate
that at least some of the interactions we observed in vitro
do exist in virions or/and in infected cells and to test their
importance in the selective packaging of the interacting
vRNAs. An important step towards this goal is the
precise identiﬁcation of the nucleotides involved in ﬁve
vRNA/vRNA interactions (Figures 5–10). In addition,
for two interactions, we conﬁrmed the existence of the
base pairing using compensatory mutations in the two
interacting vRNAs (Figure 9 and 10). As the interacting
sequences we identiﬁed are all located in coding regions (in
antisense orientation) (Figure 5), testing the existence and
function of these interactions in cell culture will ideally
involve using silent compensatory mutations. However,
as usually only the third base of the codons can be
mutated without affecting the protein sequence, it is gen-
erally not possible to design such mutants. For instance,
the mutations engineered in vRNA 3 to test the interaction
with vRNA 8 are silent, but those in vRNA 8 are not
(Figure 9E). However, the mutations introduced in
vRNAs 1 and 2 to test their interaction are both silent
(Figure 10D). This pair of mutants, or similar ones,
opens up the possibility to study the existence and the
functional role of some of the vRNA/vRNA interactions
we detected in vitro and to test the hypothesis that vRNA/
vRNA interactions might drive the selective incorporation
of vRNPs into IAV budding particles (3,26). Indeed, work
in progress in our laboratories indicated that the inter-
action between vRNAs 2 and 8 does take place in vivo
and participates in the selective packaging of these
vRNAs (Gavazzi, C. et al., in preparation).
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